These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18430190)

  • 1. Prognostic significance of failure to cross esophageal tumors by endoluminal ultrasound.
    Morgan MA; Twine CP; Lewis WG; Lambe R; Oliphant HE; Robinson M; Crosby TD; Roberts SA
    Dis Esophagus; 2008; 21(6):508-13. PubMed ID: 18430190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of restaging endoscopic ultrasound after neoadjuvant therapy for esophageal cancer.
    Griffin JM; Reed CE; Denlinger CE
    Ann Thorac Surg; 2012 Jun; 93(6):1855-9; discussion 1860. PubMed ID: 22516835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response evaluation with endoscopic ultrasound and computed tomography in esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Chang WL; Wang WL; Chung TJ; Lin FC; Yen CJ; Lai WW; Yang HB; Sheu BS
    J Gastroenterol Hepatol; 2015 Mar; 30(3):463-9. PubMed ID: 25088453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation between endoscopic ultrasound evaluation and survival of patients with inoperable thoracic squamous cell carcinoma of the oesophagus treated by combined radio- and chemotherapy.
    Giovannini M; Bardou VJ; Moutardier V; Bernardini D; Resbeut M; Capodano G; Seitz JF
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):593-7. PubMed ID: 10604099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the endoscopic ultrasound defined lymph node metastasis count in esophageal cancer.
    Twine CP; Roberts SA; Rawlinson CE; Davies L; Escofet X; Dave BV; Crosby TD; Lewis WG
    Dis Esophagus; 2010 Nov; 23(8):652-9. PubMed ID: 20545976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ultrasound in restaging of esophageal cancer after neoadjuvant chemoradiation.
    Isenberg G; Chak A; Canto MI; Levitan N; Clayman J; Pollack BJ; Sivak MV
    Gastrointest Endosc; 1998 Aug; 48(2):158-63. PubMed ID: 9717781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.
    Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF
    Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma.
    Higuchi I; Yasuda T; Yano M; Doki Y; Miyata H; Tatsumi M; Fukunaga H; Takiguchi S; Fujiwara Y; Hatazawa J; Monden M
    J Thorac Cardiovasc Surg; 2008 Jul; 136(1):205-12, 212.e1-3. PubMed ID: 18603077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of esophageal cancer and degree of luminal stenosis during upper endoscopy predict T stage by endoscopic ultrasound.
    Bhutani MS; Barde CJ; Markert RJ; Gopalswamy N
    Endoscopy; 2002 Jun; 34(6):461-3. PubMed ID: 12048628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between definitive chemoradiotherapy and esophagectomy in patients with clinical stage I esophageal squamous cell carcinoma.
    Yamamoto S; Ishihara R; Motoori M; Kawaguchi Y; Uedo N; Takeuchi Y; Higashino K; Yano M; Nakamura S; Iishi H
    Am J Gastroenterol; 2011 Jun; 106(6):1048-54. PubMed ID: 21343920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer.
    Zuccaro G; Rice TW; Goldblum J; Medendorp SV; Becker M; Pimentel R; Gitlin L; Adelstein DJ
    Am J Gastroenterol; 1999 Apr; 94(4):906-12. PubMed ID: 10201455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
    Chang DT; Chapman C; Shen J; Su Z; Koong AC
    Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment.
    Wieder HA; Brücher BL; Zimmermann F; Becker K; Lordick F; Beer A; Schwaiger M; Fink U; Siewert JR; Stein HJ; Weber WA
    J Clin Oncol; 2004 Mar; 22(5):900-8. PubMed ID: 14990646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma.
    Yen TJ; Chung CS; Wu YW; Yen RF; Cheng MF; Lee JM; Hsu CH; Chang YL; Wang HP
    Dis Esophagus; 2012 Jan; 25(1):40-7. PubMed ID: 21595776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of survival by tumor area on endosonography after definitive chemoradiotherapy for locally advanced squamous cell carcinoma of the esophagus.
    Shim CN; Song MK; Lee HS; Chung H; Lee H; Shin SK; Lee SK; Lee YC; Park JC
    Digestion; 2014; 90(2):98-107. PubMed ID: 25196528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer.
    Kulke MH; Odze RD; Mueller JD; Wang H; Redston M; Bertagnolli MM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1579-86. PubMed ID: 15173710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single institutional non-randomized retrospective comparison between definitive chemoradiotherapy and radical surgery in 82 Japanese patients with resectable esophageal squamous cell carcinoma.
    Yamashita H; Nakagawa K; Yamada K; Kaminishi M; Mafune K; Ohtomo K
    Dis Esophagus; 2008; 21(5):430-6. PubMed ID: 19125797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients.
    Chak A; Canto MI; Cooper GS; Isenberg G; Willis J; Levitan N; Clayman J; Forastiere A; Heath E; Sivak MV
    Cancer; 2000 Apr; 88(8):1788-95. PubMed ID: 10760753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.